chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her throat was swollen; swelling inside of the mouth and under her lip; swelling inside of the mouth and under her lip; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration, administered in Arm Right on 28Jan2021 13:00 as dose 2, single for covid-19 immunisation.  Medical history included she has a lot of food a lot of food allergies, She is very allergic to poppy seeds. Patient had no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL0140), via an unspecified route of administration, administered in Arm Right on 07Jan2021 13:00 as dose 1, single for covid-19 immunisation and experienced swelling of her throat, it felt like it was kind of closing, reflux and . On Jan2021, the patient experienced her throat was swollen, swelling inside of the mouth and under her lip and swelling under her upper lip. Caller mentioned that she received the 1st dose of the vaccine 07Jan2021 and within 24-48 hours felt a little feeling of swelling of her throat. It felt like it was kind of closing. She got an EMT Scope and they saw that her throat was swollen. They thought that it was because of reflux and gave her reflux medications which did not help. She received the 2nd dose of the vaccine 28Jan2021 and about a day or 2 later the same feeling in her throat appeared. She went to the EMT and was told that her throat was swollen. She also reported a swelling inside of the mouth and under her lip. She was prescribed Benadryl and prednisone with the 6, 5, 4, 3, 2, 1 dosing regimen but it did not help her symptoms. She was not better and these symptoms are scaring her. She mentioned that the doctors did not know what to do. She is asking if anybody reported any closing of the throat symptoms (later clarified to allergic reactions) and what to do. Caller asked if having any food allergies could affect the experience with the vaccine. She mentioned that she has a lot of food a lot of food allergies including nuts, and seeds. She is very allergic to poppy seeds and would like to know if any ingredients have been derived from poppy seeds. Therapeutic measures were taken as a result of her throat was swollen, swelling inside of the mouth and under her lip, swelling inside of the mouth and under her lip. The clinical outcome of events were not recovered.  No follow up attempts are possible. No further information is expected.
Patient presented 0n 5/25/21 with chest pain, shortness of breath, nausea and headache.  Work-up showed pericardial effusion with pericarditis. Drain placed. Patient responded to ibuprofen and colchicine therapy.  Patient unsure of dates of vaccination.  Stated April-May 2021.
Per recovery RN notes: Patient stated nose is "feeling numb". No other symptoms noted. Instructed patient to remain in waiting room until symptoms  subsides. At approximately 1350, patient stated feeling "numb and stuffy, and lightheaded". SPO2 at 99% room air. Pulse rate at 61bpm. No new symptoms noted at 1407. Will continue to monitor. Per patient, lightheadedness subsided at approximately 1415. Stated "numbness and stuffy nose" improving. At approximately 1445, patient stated symptoms subsided. Patient left facility at 1446, in stable condition.
Received vaccination on 3/28/03. Four days post vac developed non-pruritic, plaques and patches on arms, back, chest, abd, legs. Spares face, palms and soles. Blanching. Would evolve and resolve at several different sites. Seen by dermatologist on 4/3. Diagnosed as urticaria. Treated with antihistamines and prn steroid cream.
Erythema, swelling, pain, and warmth that started the night of the injection. Has continued on evaluation three days after the injection.
Within a week after first booster shot I delevoped a continuous cough especially at night it lasted a solid 6 weeks before subsiding. Multiple muscles have  become very tight especially in the chest. Visited the doctor twice during this time and was diagnosis with bronchitis and then a sinus inflection.  A week later multiple teeth were aching.  Dentist diagnosis the problem as tighten jaw muscles.  Applying a cold pack behind the ear eliminated the pain.  The tooth aches returned later and the cold pack worked again. My husband and I took the same booster shot at the same time.  We are both very healthy and did not have any negative affects from the previous two shots. Within days after the booster shots we both started coughing and it lasted for weeks.  . It has been over four months since the booster shots and we do not feel well with aches, pains, coughing, lack of energy, and hard to breath.
Weak; lightheaded; cotton mouth; difficulty breathing; HA. Evaluated by EMS-cleared.
Fever; Chills; vomiting; body aches; wobbly legs and arms/weakness in legs and arms; headache; nausea; lightheaded; Swollen and red and hot at the injection site; Swollen and red and hot at the injection site; Swollen and red and hot at the injection site; fatigue; swollen lymph node in chest; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via unspecified route of administration in the left arm on 22Mar2021 at 15:30 (at the age 53-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic pericarditis. The patient was allergic to penicillin. Concomitant medications included colchicine (MANUFACTURER UNKNOWN) 20 mg, bifidobacterium infantis; lactobacillus acidophilus (PROBIOTIC), fish oil (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198); via unspecified route of administration in the left arm on 01Mar2021 at 15:30 (at the age 53-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 20:00, the patient experienced fever, chills, vomiting, body aches, wobbly legs and arms, headache, nausea, light-headed, swollen and red and hot at the injection site, fatigue, weakness in legs and arms and swollen lymph node in chest. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatments for the events. The clinical outcome of the events fever, chills, vomiting, body aches, headache, nausea, lightheaded, vaccination site swelling and vaccination site erythema and vaccination site warmth, fatigue, weakness in legs and arms and swollen lymph node in chest was not recovered.   No follow-up attempts are needed. No further information is expected.
The morning after the innoculations I had a headache, sore muscles, pain and swelling at the injection site, and a fever. The fever reached a maximum of 103.4 at 5:30 PM on June 9,2005.  Tylenol and Ibuprufen were taken to reduce the fever.  A course of Cephalexin was started at 11:30 PM on June 10.  Temperature returned to normal by the morning of June 11.  The headache and sore muscles had subsided by that time, as well.  The injection site on the right arm was still sore and red (3 inches in diameter) for more than 2 weeks.
Making it difficult for her to go about her daily life; Ringing in the head one day after first dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in the head one day after first dose of Moderna vaccine) and MALAISE (Making it difficult for her to go about her daily life) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Psychiatric disorder NOS. Concomitant products included PALIPERIDONE PALMITATE (INVEGA SUSTENNA), METFORMIN, GLIPIZIDE, SIMVASTATIN and SITAGLIPTIN PHOSPHATE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced TINNITUS (Ringing in the head one day after first dose of Moderna vaccine). On an unknown date, the patient experienced MALAISE (Making it difficult for her to go about her daily life). At the time of the report, TINNITUS (Ringing in the head one day after first dose of Moderna vaccine) and MALAISE (Making it difficult for her to go about her daily life) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up information received on 11-May-2021 contains significant information: updated information of dosage route of administration and also updated reporter's address.
Rash developed from Belly Button up to jaw line front and back sides of Torso and neck but no upper extremities , Red like a sunburn but with petechiae through out the full redness also  and hot to touch. Stayed Friday PM through Sunday PM at bedtime. Woke up Monday AM without rash.
A repot was received from a health care professional on 7OCT2003 concerning a 39 year old male vaccinee who experienced an accidental overdose, after inadvertently receiving Fluvirin vaccine on 29SEPT2003 and again on 3OCT2003. On 3OCT2003, the vaccinee experienced an accidental overdose after inadvertently receiving a second Fluvirin vaccination 4 days after the first vaccination. No adverse effects were reported at time of report. There was insufficient information to determine the reporter's causality assessment. Update 1 28OCT2003: Follow up information received from a health care professional indicated that the vaccinee had still not experienced any adverse reaction at the time of this report. No follow up pending.
swelling of throat, difficulty swallowing. patient went to emergency room after leaving and reported diagnosis of anaphylaxis
48 hours after vaccine joint swelling and pain in wrist, ankles and feet.  Required medical treatment with Prednisone.  Ongoing treatment to date (6/3/21).
Meningeal symptoms beginning on 7/20/01.Pt also had a headache, nausea, dizziness and severe malaise.
Began feeling tinge in arm from mid upper arm to elbow.  Unable to golf later in the day. Increasing pain over next 4 days. ER visit on 10/14/10 with CMP, CK MB Profile and EKG.  R/O cardiac event.  Given Tylenol #3 for pain and instructed patient to use ice/ heat to affected area.  Patient followed up with PCP on 10/15/10.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult patient who received SHINGRIX. On 23rd May 2018, the patient received the 2nd dose of SHINGRIX. In May 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain and erythematous rash. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the erythematous rash was not recovered/not resolved. It was unknown if the reporter considered the injection site pain and erythematous rash to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The adverse reactions experienced by the patient, after vaccination was minor. For two days the patient had injection site soreness. On the second day of the vaccination she noticed a square red rash with size about 2 and half inch by 2 and half inch. It was still there on the day of reporting (day 3rd of vaccination), but noticeably lighter and the pain was greatly diminished.
This 43 year old received routine TD vac to his lt deltoid on 18 May 2005 along w/his PPD (lt forearm).  He reports common adverse events of fever, body aches and pain at injection site w/deltoid swelling for 2 days.  Symptoms were treated with NSAID w/relief. Friday 5/20/05 he used a rear wheel drive lawnmower. 2 days later, he reports reoccurrence of left arm, chest wall spasm and pain with increased pain on deep breathing and lifting/pushing w/left arm. He is self treating with NSAID, Feldene w/some easing but spasms persist.  He is concerned about duration of discomfort, reason for and if he'll lose function of his left arm.  He denies paresthesia, cold-hot temp changes, no fevers, illness, trauma, bites, arm/hand swelling, or change in pulse.
Severe body aches the day after with abnormal headache that increased with bending over.  Easily bruising to the back of my left thigh from exiting and entering the golf cart and right arm after leaning against the corner of the wall with sensitivity to my skin. Developed lumps under the skin at the bruising site to the back of my left thigh which remain present, however are slowly decreasing in number and size, slightly tender.   Today slight dizziness developed with uneasy feeling in my stomach.
PATIENT RECEIVE THE ADJUVANT ONLY; PATIENT RECEIVE THE ADJUVANT ONLY; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number Z7GH5, expiry date 25th January 2024) for prophylaxis.   On 15th November 2022, the patient received Shingrix. On 15th November 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 15-NOV-2022 Reporter's comment: The nurse called to asked for information about the administration of only the adjuvant component of Shingrix to three patients.  The reported asked for information about safety and re vaccination. The reporter provided the identifiers of two patients and mentioned that she will call back once she get the data of the third patient. The reporter consented to follow-up. This case was for 1 of 3 linked patients reported by same reporter. Additional supportive information: The patient only received the adjuvant component of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.; Sender's Comments:  US-GSK-US2022170378:Same reporter US-GSK-US2022170376:Same reporter
Pt recvd 3 doses of Hep B vax in 1989 & failed to seroconvert (WAES91061069) & on 11JUN91 @ 9AM the pt recvd 1st dose of Hep B & 3 hrs following vax devel flu-like rxn characterized by nausea, malaise, diaphoresis, chills & a fever;
This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (red) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On 06-Jan-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE ERYTHEMA (red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information provided. Most recent FOLLOW-UP information incorporated above includes: On 18-Jan-2021: No specific follow-up information recorded.
Patient received only the liquid portion of Rotarix; Patient received only the liquid portion of Rotarix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 4-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number L5G93, expiry date 27th August 2021) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 27th April 2021, the patient received Rotarix lyophilized formulation (oral) and Rotarix Oral Applicator Device. On 27th April 2021, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The medical assistant reported that, the patient received only the liquid portion of Rotarix (without the powder component), which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow-up.
Fever repeatedly came back throughout the following week. Felt weak, exhausted, full body aches. Very poor working memory still has not gotten better after two weeks. Slight loss of balance. Increased depression and anxiety.
All of her shots gave her typical side effects; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (All of her shots gave her typical side effects) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Ear infection (ear infection once ,20 years ago). Concurrent medical conditions included Blood pressure high and Penicillin allergy.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (All of her shots gave her typical side effects). At the time of the report, IMMUNISATION REACTION (All of her shots gave her typical side effects) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient weight reported as 120. Patient did not had COVID test or diagnosis  No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2022-566651, MOD-2022-566654, MOD-2022-566656 (Patient Link).
Patient developed intermittent severe crying WITH failure to pass stool for one day. She got RotaTeq a week prior to onset of illness. KUB and Barium enema were suggestive of Intussusception. Reduction of intusussception made by barium enema hydrostatic pressure. Patients symptoms resolved.
had sore left arm for a couple of days; she has a little thing under the skin of the left arm ,said she used to have it when she was younger , and now it appeared again,; had done the rapid test , it was negative for Covid, had no symptoms; she spent the weekend with her brother in law, and on Monday he tested positive for Covid; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (she spent the weekend with her brother in law, and on Monday he tested positive for Covid), PRE-EXISTING CONDITION IMPROVED (had done the rapid test , it was negative for Covid, had no symptoms), PAIN IN EXTREMITY (had sore left arm for a couple of days) and SKIN DISORDER (she has a little thing under the skin of the left arm ,said she used to have it when she was younger , and now it appeared again,) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032LL20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced COVID-19 (she spent the weekend with her brother in law, and on Monday he tested positive for Covid). On 23-Feb-2021, the patient experienced PRE-EXISTING CONDITION IMPROVED (had done the rapid test , it was negative for Covid, had no symptoms) and SKIN DISORDER (she has a little thing under the skin of the left arm ,said she used to have it when she was younger , and now it appeared again,). On an unknown date, the patient experienced PAIN IN EXTREMITY (had sore left arm for a couple of days). On 21-Feb-2021, COVID-19 (she spent the weekend with her brother in law, and on Monday he tested positive for Covid) had resolved. At the time of the report, PRE-EXISTING CONDITION IMPROVED (had done the rapid test , it was negative for Covid, had no symptoms), PAIN IN EXTREMITY (had sore left arm for a couple of days) and SKIN DISORDER (she has a little thing under the skin of the left arm ,said she used to have it when she was younger , and now it appeared again,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, COVID-19: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
From initial information received on 9/7/04 from a registered nurse who is also the patient, regarding an adverse event occurring in the USA, it was reported that a 44 year old female patient received a TD ADS ADULT vaccination, lot number U1347AA, administered in the left upper deltoid on 9/3/04. The same day, the patient developed a sore neck and arm, a local reaction of knot formation at the injection site, fever of 101 degrees F, chills and hives on her back and chest. She self-medicated with Advil. The patient recovered from these events within 12 hours. From additional information received on 10/19/04 from a physician, the patient's full name address and telephone number were provided. No further information is anticipated. This case is considered closed. The reporter of this case is the same reporter as case 200402988.
1. Got 1st shot Modena on left arm on January 17, 2021, usual headache sore muscle and tired for a day. 2. Blood pressure shot up  to 159 accidentally when visit dental office on January 27, 2021 3. Got 2nd shot Modena on left arm on February 16, 2021, usual sore muscle, better than after 1st shot. 4. Blood pressure continue to shot up to 169 when visit up night guard on Feb 24, 2021 5. Visit primary Dr, blood pressure continued to be as high as 159. 6. On April 23, 2021, while visit dental office, blood pressure shot up to 179/75 causing personnel alarm and advise to talk to PCP. 7. Checking Blood pressure daily at home using portable wrist cuff:  upper number measurement ranged from  140 to 197 in the last week as I checked daily, morning, noon and evening.